TNFRSF12A and acute kidney injury: Additionally, some novel biomarkers for managing AKI are oncoming, such as ferroptosis-related gene Gclc [240], inflammatory biomarkers CXCL1 and TNFRSF12A [241], kidney-specific cfDNA methylation markers [242].